Visit Summary

This report displays the following information about the visits in a study.

This table describes all possible fields for the report. Data in the report appears only in fields applicable to the study. Some fields might not appear in your report, and some fields could have different names.

Column	Description
Region	Area defined by the study team where the site is located (example: South America).
Country	Country where the site located (example: Brazil).
Investigator ID	Unique identification number for the investigator.
Site	Unique identification number for the site.
Name	Last name and first name of the Principal Investigator as entered at the site level.
Subject Number	Unique identification number for the subject.
Screening Number	Unique identification number assigned at screening. Typically, this is the same as the Subject Number.
Active	Whether the subject is active. Yes—Subject has a status of Screened or Randomized. No—Subject has a status of Screen Failed, Early Terminated, or Completed.
Visit Name	Description of the visit or transaction that affects the subject. Unblinding is excluded. Dynamic visits such as Drug Replacement, Edit Subject Data, and Subject Transfer visits appear on this report as they occur.
Scheduled	Expected visit date based on the randomization date and the visit schedule.
Actual	Date the visit occurred.
Allocated	Drug unit number(s) dispensed at the visit.
Replaced	Drug unit number(s) replaced and the status of each replaced unit (example: Missing or Damaged).
Missed Visit	Name of missed visit OR Date of missed visit.